Inogen Inc (INGN)
6.94
-0.01
(-0.14%)
USD |
NASDAQ |
Apr 17, 16:00
6.94
0.00 (0.00%)
After-Hours: 20:00
Inogen Cash from Operations (TTM): -3.234M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -3.234M |
September 30, 2023 | -15.57M |
June 30, 2023 | -27.24M |
March 31, 2023 | -25.74M |
December 31, 2022 | -37.53M |
September 30, 2022 | -15.55M |
June 30, 2022 | -9.063M |
March 31, 2022 | 2.675M |
December 31, 2021 | 23.63M |
September 30, 2021 | 33.33M |
June 30, 2021 | 43.07M |
March 31, 2021 | 39.33M |
December 31, 2020 | 37.01M |
September 30, 2020 | 30.20M |
June 30, 2020 | 38.06M |
March 31, 2020 | 42.96M |
December 31, 2019 | 40.59M |
September 30, 2019 | 43.54M |
June 30, 2019 | 43.32M |
March 31, 2019 | 45.91M |
December 31, 2018 | 59.98M |
Date | Value |
---|---|
September 30, 2018 | 60.65M |
June 30, 2018 | 63.65M |
March 31, 2018 | 59.52M |
December 31, 2017 | 60.49M |
September 30, 2017 | 52.67M |
June 30, 2017 | 44.35M |
March 31, 2017 | 39.47M |
December 31, 2016 | 31.03M |
September 30, 2016 | 38.41M |
June 30, 2016 | 41.21M |
March 31, 2016 | 36.88M |
December 31, 2015 | 38.16M |
September 30, 2015 | 29.93M |
June 30, 2015 | 21.29M |
March 31, 2015 | 23.09M |
December 31, 2014 | 15.70M |
September 30, 2014 | 13.36M |
June 30, 2014 | 14.75M |
March 31, 2014 | 9.444M |
December 31, 2013 | 13.47M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-37.53M
Minimum
Dec 2022
43.54M
Maximum
Sep 2019
14.94M
Average
30.20M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
Oragenics Inc | -7.291M |
Palatin Technologies Inc | -26.54M |
Oramed Pharmaceuticals Inc | -10.30M |
vTv Therapeutics Inc | -19.08M |
G1 Therapeutics Inc | -38.34M |